Diamond Hill Capital Management
NVS icon

Diamond Hill Capital Management’s Novartis NVS Stock Holding History

Diamond Hill Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89M Hold
24,822
– – 0.03% 159
2026
Q1 		$3.79M Hold
24,822
– – 0.02% 155
2025
Q4 		$3.42M Sell
24,822
-3,005
-11% -$394K 0.02% 158
2025
Q3 		$3.57M Sell
27,827
-6,450
-19% -$787K 0.02% 154
2025
Q2 		$4.15M Hold
34,277
– – 0.02% 146
2025
Q1 		$3.82M Buy
34,277
+3,562
+12% +$379K 0.02% 138
2024
Q4 		$2.99M Buy
30,715
+3,715
+14% +$396K 0.01% 153
2024
Q3 		$3.11M Hold
27,000
– – 0.01% 147
2024
Q2 		$2.87M Buy
27,000
+3,466
+15% +$348K 0.01% 144
2024
Q1 		$2.28M Buy
23,534
+2,560
+12% +$262K 0.01% 144
2023
Q4 		$2.12M Buy
20,974
+845
+4% +$81.6K 0.01% 145
2023
Q3 		$2.05M Buy
20,129
+1,600
+9% +$162K 0.01% 143
2023
Q2 		$1.87M Sell
18,529
-1,420
-7% -$142K 0.01% 146
2023
Q1 		$1.84M Sell
19,949
-1,527
-7% -$133K 0.01% 145
2022
Q4 		$1.95M Hold
21,476
– – 0.01% 142
2022
Q3 		$1.63M Buy
21,476
+1,497
+7% +$124K 0.01% 143
2022
Q2 		$1.69M Hold
19,979
– – 0.01% 143
2022
Q1 		$1.75M Hold
19,979
– – 0.01% 140
2021
Q4 		$1.75M Buy
19,979
+6,078
+44% +$505K 0.01% 139
2021
Q3 		$1.14M Buy
13,901
+5,210
+60% +$469K ﹤0.01% 139
2021
Q2 		$793K Buy
8,691
+1,135
+15% +$101K ﹤0.01% 138
2021
Q1 		$646K Buy
7,556
+485
+7% +$43.5K ﹤0.01% 136
2020
Q4 		$668K Buy
7,071
+3,240
+85% +$283K ﹤0.01% 141
2020
Q3 		$333K Buy
3,831
+390
+11% +$33.8K ﹤0.01% 143
2020
Q2 		$301K Hold
3,441
– – ﹤0.01% 146
2020
Q1 		$284K Buy
3,441
+440
+15% +$39.3K ﹤0.01% 141
2019
Q4 		$284K Buy
3,001
+480
+19% +$43.1K ﹤0.01% 149
2019
Q3 		$219K Buy
+2,521
New +$226K ﹤0.01% 159

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

Diamond Hill Capital Management's NVS Position: Q2 2026 in Review

Diamond Hill Capital Management held its Novartis (NVS) position steady in Q2 2026 at 24,822 shares worth $3.89M. The position accounts for 0.03% of the portfolio, ranked #159.

Diamond Hill Capital Management first reported a position in NVS in Q3 2019 and has held it in 28 quarters since. The position peaked at $4.15M in Q2 2025. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Diamond Hill Capital Management held 24,822 shares of Novartis worth $3.89M as of Q2 2026.
  • Diamond Hill Capital Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.03% of Diamond Hill Capital Management's portfolio in Q2 2026, its #159 holding.
  • Diamond Hill Capital Management first reported a position in Novartis in Q3 2019 and has held it in 28 quarters since.
  • Diamond Hill Capital Management's Novartis position peaked at $4.15M in Q2 2025.
  • 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Diamond Hill Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.